In summary, this Notice is to inform you that a conditional settlement of AUD$38 million (Settlement Sum), inclusive of legal fees, expenses, disbursements, any funding commission and interest, to resolve the claims of all Group Members has been reached in the Mayne Pharma Class Action (Proposed Settlement). The Proposed Settlement is without admission of liability by Mayne Pharma Group Ltd (Mayne Pharma)
(a) contravened its continuous disclosure obligations between 24 November 2014 and 15 December 2016
(b) engaged in misleading or deceptive conduct between 24 November 2014 and 15 December 2016
The Court will have a hearing at 10:30am AEDT on 8 November 2024 to determine whether to approve the proposed settlement.
